Our findings highlight the contribution of neural/glial MMP-9 to Aβ-induced neurotoxicity and cognitive impairment and support the idea that for highly selective MMP-9, inhibitors may reduce deleterious proteolytic activity and neuronal death in Alzheimer's disease. The gene discussed is MMP9; the disease is Cognitive impairment.